- Research article
- Open Access
- Open Peer Review
Isolation and characterization of side population stem cells in articular synovial tissue
BMC Musculoskeletal Disorders volume 9, Article number: 86 (2008)
Autologous chondrocyte implantation is an established technique for the repair of degenerated articular cartilage. Recently, the detection of side population (SP) cells, which have the ability to strongly efflux Hoechst 33342 (Ho) fluorescence dye, has attracted attention as a method of stem cell isolation. Although SP cells from synovial tissue were expected to be an excellent source for this tissue engineering, their precise character in the synovial tissue has not been determined.
Synovial tissues from bovine metacarpophalangeal joints were used as a stem cell source. For efficient collection of stem cells, we first prepared a preculture before sorting in medium containing FBS at variable concentrations for 4 days. Using a cell sorter and the Ho-dye, a poorly stained population enriched with stem cells was then isolated. To determine the characteristics of the stem cells, specific marker genes such as CD34, Flk-1, c-Kit, Abcg-2 were identified by real-time PCR. Sorted SP cells were cultured in a stem cell medium supplemented with bFGF, SCF and fibronectin, and evaluated for their differentiation potentials into chondrocytes, osteocytes and myocytes.
SP cells of synovium tissue were increased from 2% of the total cell population to approximately 10% of the total cells by preculture in the 1%FBS contained medium. Sorted SP cells expressed CD34, Flk-1, c-Kit, Abcg-2 and Mdr-1 -all are important marker genes for stem cell characteristics. The SP cells could be further expanded ex vivo while maintaining stem cell potentials such as marker gene expression, Ho-dye efflux potential and multiple differentiation potentials into chondrocyte, osteocyte and myocyte.
In the present study, we demonstrated that the cells with outstanding stem cell properties were efficiently collected as a SP fraction from bovine synovial membrane. Furthermore, we have described an efficient isolation method and the culture conditions for ex vivo expansion that maintains their important characteristics. Our results suggest that the SP cells of synovium tissue might be important candidates as sources for cell transplantation.
Lesions on articular cartilage are difficult to heal spontaneously, and there is no effective strategy for inducing their repair. Autologous chondrocyte implantation (ACI) is now an established technique for the repair of symptomatic isolated lesions of articular cartilage in young adults [1, 2]. However, surgical invasion of normal articular cartilage and limited ex vivo expansion of the chondrocytes lead to difficulties in repairing large defects.
Stem cells from synovium membrane have been viewed as fascinating potential sources for regenerative medicine since they possess high chondrogenic properties [3, 4] and are possible to be prepared from the joint without damaging the healthy articular cartilage. However, the specific cell markers of these have not yet been determined, and a way for efficient purification also has not been developed.
Recent developments in stem cell biology demonstrated the presence of side population (SP) cells. They are identified by their unique fluorescence-activated cell sorting (FACS) profile, regardless of tissue origin. When separated by a flow cytometer with a UV laser, SP cells are distinct from cells that take up the Hoechst 33342 (Ho) dye . The SP phenotype is determined by the BCRP1/ABCG2 gene that is expressed in pluripotent ES cells and multipotent somatic stem cells . Isolation of SP stem cells by the Ho-dye and FACS technique has been reported in muscular tissue [7, 8], liver [9, 10], lung , skin , uterus , testis  and cornea [15, 16] at present.
It was reported that SP stem cells of bone marrow origin displayed strong hematopoietic reconstituting activity as measured by competitive repopulation assays , and marrow SP cells also give rise to endothelial cells and skeletal and cardiac muscles [7, 8, 17]. Moreover, SP cells from the skeletal muscle might be reconstituted as both the skeletal muscle and the hematopoietic system of recipients. From these, it is expected that the SP stem cells of somatic tissues possess superior properties, and it is easy to surmise that SP cells in synovium tissues also possess valuable properties compared to other types of somatic cells, and are expected to be a better source of regenerative medicine.
SP stem cells of synovium tissue have been found by Yamane et al., to possess high chondrogenic properties ; however, the precise characteristics such as stem cell marker gene expression profiles or multiple differentiation properties were not determined. Furthermore, the culture system for the SP stem cells has not been developed.
In the present study, we determined that the SP cells expressed important stem/progenitor cell markers CD34, Flk-1, c-Kit and Abcg-2, and they possessed multiple differentiation potentials to differentiate into chondrocyte, osteocyte and myocyte. Furthermore, we also succeeded in expansion in vitro without losing these properties. Our method suggests a way to amplify necessary stem cells from a little volume of tissue, it might be an effective way to prepare materials for regenerative medicine.
Preparation of synovial cells
Fibrous synovial membrane (wet weight 1.5–2.5 g) was obtained aseptically from the metacarpophalangeal joint of freshly slaughtered calves about 10 months of age, which was kindly gifted from the local slaughterhouse. The specimens were rinsed twice with PBS supplemented with penicillin, streptomycin and amphotericin B, and minced well. They were then digested with 0.1% collagenase (Sigma-Aldrich, St. Louis, MO, USA) in Dulbecco's modified Eagle's medium (DMEM-1; Nissui Pharmaceutical, Tokyo, Japan) containing 10% fetal bovine serum (FBS; Hyclone Laboratories Inc., Logan, UT, USA. Lot no. KPK22095) and Penicillin – Streptomycin – Amphotericin B mixture (Antibiotic-Antimycotic; Invitrogen Corporation, Carlsbad, CA, USA.) for 8 hours at 37°C. Following digestion, the cells were filtered through a 100-μm mesh. The filtrate was centrifuged, washed twice with PBS and stored on ice until further use.
Hoechst 33342 exclusion assay using fluorescence-activated cell sorting
Released cells were resuspended at a concentration of 106 cells/ml in FACS buffer composed of DMEM (DMEM-2; Nissui Pharmaceutical) plus 2% FBS, 10 mM HEPES and antibiotics. For preliminary study, we performed Hoechst33342 (Ho; Sigma-Aldrich. Lot no. 017K4122) staining at various concentrations (1, 1.2, 1.4, 1.6, 1.8, 2, 3, 4 and 5 μg/ml) followed by FACS analysis, and confirmed optimal concentrations as 1.8 to 2.0 μg/ml in our system. For analyzing the rates of SP fractions, cell suspensions were incubated in FACS buffer containing Ho-dye at 1.8 μg/ml for 90 minutes at 37°C. For sorting, cells were stained with 2.0 μg/ml under the same conditions to perform subsequent analysis closely. As a negative control for the Ho staining, 50 μM verapamil (Ver; Sigma-Aldrich. Lot no. 096K4617), which blocks the ABC membrane transporter from extruding the Hoechst dye, was added to an aliquot of cell solution. After staining, cells were washed twice with ice-cold FACS buffer, centrifuged and resuspended. Cell sorting was performed using a dual-laser fluorescence-activated cell sorter (FACS VantageSE, Becton Dickinson, San Jose, CA, USA). Ho was excited by an argon multiline UV laser (333.4- to 363.8-nm; COHERENT, Santa Clara, CA, USA.), and fluorescence emission was detected through 450-nm band-pass (Hoechst blue) and 675-nm long-pass (Hoechst red) filters, respectively. Cells showing reduced fluorescence of both blue and red were collected as SP cells. Stained control cells were classified as non-side population (NSP) cells.
Preculture for efficient collection of SP cells
Digested and filtered cells were cultured on gelatin-coated dishes at 1.5 × 106 cells/100-mm dish in DMEM or StemPro-34SFM (Invitrogen) supplemented with antibiotics, 0.1 mM pyruvate and 1, 5, 10, 15% FBS. After 4 day's culture, the cells were released from culture dishes with 0.25% trypsin-0.02% EDTA for 3 min, centrifuged and washed with 10% FBS-containing DMEM. The cells were then used for FACS sorting.
Ex vivo expansion of sorted SP cells
Precultured and sorted SP cells were plated onto fibronectin (Fn; BD Falcon, Oxnard, CA, USA) coated 24-well dishes at 10,000 cells per well in Stem Pro-34SFM supplemented with 1%FBS, 10 ng/ml human recombinant basic FGF (bFGF; Upstate, Charlottesville, VA, USA), 25 ng/ml human recombinant stem cell factor (SCF; Peprotech Inc., Rocky Hill, NJ, USA) and insulin-transferrin-serenium (ITS-G; Invitrogen). When 80%–90% confluent, cells were trypsinized and subcultured on Fn coated 35 mm dishes at 5 × 104 cells per dish. After passaging to 35 mm dish, the culture medium was changed every other day. Passaging was performed every 3 days and continued 12 times.
In vitro differentiations into chondrocytes, osteocytes and myocytes
Precultured and sorted cells were harvested onto fibronectin-coated dishes, and cultured in 1% FBS containing StemPro-34SFM supplemented with 10 ng/ml human recombinant basic FGF (bFGF; Upstate, Charlottesville, VA, USA), 25 ng/ml human recombinant stem cell factor (SCF; Peprotech Inc., Rocky Hill, NJ, USA) and insulin-transferrin-serenium (ITS-G; Invitrogen). To confirm the differentiation potency, we used 7-times passaged cells for the differentiation experiment.
The in vitro chondrogenesis assay was performed by pellet culture. 2.0 × 105 viable SP and NSP cells were centrifuged, and the cells were cultured in DMEM (Nissui Pharmaceutical) supplemented with 5%FCS, ITS, 10 ng/mL transforming growth factor β1 (TGF-β1) (R&D Systems, Abingdon, UK), 10 nM dexamethasone (Sigma-Aldrich), 10 mg/mL ascorbic acid (Sigma-Aldrich), and antibiotics (Invitrogen). After 3 weeks, pellets were fixed with 10% formalin, embedded in tissue-tek compound, sectioned at 7-μm and stained with toluidine-blue and alcian-blue according to standard protocols using cryosections prepared from a bovine articular cartilage as controls [see Additional file 1].
For osteocyte induction, cells were plated at 3 × 103/cm2 in 12-well tissue culture plate and cultured in 10%FBS-DMEM contained 100 nM dexamethasone, 10 mM ascorbic acid, and 2-glycerophasphate. Differentiated samples were tested for alkaline phosphatase (ALP) activity by alkaline phosphatase kit (SIGMA-Aldrich) and calcium deposition by staining with 1% Alizarin red-S solution.
For myocytes differentiation, cells were plated to fibronectin-coated 35-mm dishes and cultured in DMEM high-glucose, 1%FBS, antibiotics and 0.1 mM Pyruvate. After a week, the cultures were fixed, permeabilized by 0.5% Triton-X (SIGMA-Aldrich) diluted in PBS (0.5% PBT), blocked with 5% skim milk (SIGMA-Aldrich) and incubated with anti-DESMIN rabbit IgG polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA, 1:50 dilution) and kept overnight at 4°C. For immunofluorescence microscopy, the samples were incubated for 1 h at room temperature with FITC-conjugated bovine anti-rabbit IgG antibody (Santa Cruz Biotechnology, 1:1000 dilution). These samples were counterstained with propidium iodide (PI) before observation.
RNA extraction and real-time PCR analysis
Sorted cells and cultured cells were treated with TRIzol reagent (Invitrogen) and mixed thoroughly with pipetting. To dissociate the pellets of chondrocyte obtained by differentiation assay, the pellet was disrupted using a 21-G needle and syringe in TRIzol reagent. The Trizol-lysates were then mixed with chloroform and centrifuged at 15,000 × g for 15 minutes. Following centrifugation, total RNA were obtained by isopropanol precipitation according to the manufacturer's instructions. Single strand cDNA was prepared from total RNA using Random primer under standard conditions with the High Capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA, USA). Quantitative real-time PCR with total cDNA was performed using Perfect real-time SYBR green (Takara Bio, Inc., Shiga, Japan). PCR amplifications were performed with the 7700 real-time PCR System (Applied Biosystems) at 95°C for 10 sec followed by 40 cycles of 95°C for 5 s, 60°C for 30 s. To quantify the relative expression of each gene, the Ct (threshold cycle) values were normalized for endogenous reference (delta Ct = Ct target- Ct β actin) and compared with a calibrator, using the "delta-delta Ct method" (delta-delta Ct = delta Ctsample - delta Ctcalibrator) . As a calibrator, we used the average Ct value of synovium tissues obtained from three different animals. Using the delta-delta Ct value, relative expression was calculated (2-deltadeltaCt). As the delta Ct method is only applicable when the amplification efficiencies of the target and the reference are essentially equal, we determined the efficiencies for 5 dilutions, and the delta Ct values (Cttarget- Ctβ actin) were plotted against the dilution (log). The slope of the fitted line was then determined. A slope of less than 0.1 is then indicative of equal efficiencies (data not shown). The target genes in the present experiment were CD34, Flk-1, c-Kit, Abcg-2 and Mdr-1. All experiments included negative controls consisting of no cDNA for each primer pair. All samples were tested in duplicate, and the average values were used for quantification. Primers were designed to span exons to distinguish cDNA from genomic DNA products (Table 1).
RT-PCR analysis for evaluation of differentiation
The cDNA from each sample was diluted and used for an RT-PCR-based assay for type I collagen (COL1A1), type II collagen (COL2A1), CD-RAP, Aggrecan, Myo-D, Myf-5 and Osteocalcin. PCR amplifications were performed at 95°C for 2 min followed by 35 cycles of 94°C, 20 s; 58°C, 20 s; and 72°C, 20 s using Platinum Taq PCRx DNA polymerase (Invitrogen) with appropriate primers according to the manufacturer's instructions. All primers for PCR were designed on two different putative exons so as to span one intron or designed to span a putative exon-exon junction. Amplicons were analyzed by agarose-gel electro-phoresis and ethidium bromide-staining.
Statistical analysis of the data
Significant difference was detected by one-way ANOVA analysis followed by Tukey's multiple comparison tests. Comparisons between cultured SP cells and cultured NSP cells were performed by student t-test, and gene expression alteration after passages of SP cells were evaluated by Dunnet's test using the values of the SP cells at primary culture as controls. A P-value of less than 0.05 was considered significant.
Characterization of SP cells in synovial tissue
Bovine synovial cells were stained with the vital DNA dye, Hoechst 33342, and excited by a UV laser. Usually, the SP cells exhibit a low blue (440- to 460-nm) and low red (>675-nm) fluorescent staining pattern. This pattern is created by an efflux of the Hoechst 33342 dye from the SP cells. In case of the bovine synovial cells, three distinct regions were observed after excluding dead cells and debris. The cells included in population 1 (P1) and population 2 (P2) were smaller than that of population 3 (P3), and no adherent cells were observed when they were seeded on culture dishes. On the other hand, population 3 consisted of fibroblast-like cells and included a distinct side population (SP) (Figure 1). The dye exclusion property of SP cells is partly due to the functional ABC transporters and verapamil effectively blocking the ABC membrane transporter from extruding the Hoechst dye [20–24]. With the addition of verapamil, the presence of the SP fraction in region 3 was clearly eliminated [see Additional file 2], indicating that the cells in this region were candidates for stem cells. The SP cells expressed stem cell maker genes such as CD34, Flk-1, c-Kit, Abcg-2 and Mdr-1.
Preculture for expansion of SP cell
From the gene expression profiles, SP cells in P3 might be stem cells in synovial tissues. However we found that the proportion of SP cells was less than 2%, and it was clear that cell number enhancement is necessary to obtain the cells efficiently. We examined several culture conditions to amplify SP cells. This procedure was also reported to be effective for collecting SP cells from a small amount of tissues, such as corneal stroma . When synovial tissue-derived cells were cultured in ordinary medium (DMEM containing 10% FBS), only fibroblast-like cells with larger cytoplasm grew rapidly, while the rate of SP cells did not increase (Figure 2). In the culture using DMEM, altering the FBS concentration did not affect the rate of SP cells. Then, we used stem cell specific medium StemPro-34SFM. Unexpectedly, synovial tissue-derived cells neither adhered to the culture plate nor multiplied under serum-free conditions [see Additional file 3]. The result suggested that additions of growth factors and/or cell adhesion molecules contained in serum are essential to the survival of synovial tissue derived cells. Accordingly, we tested serum addition to the medium at various concentrations. The rate of cell adhesion and growth was significantly enhanced when serum was added at 1 to 5% concentrations to the medium.
In contrast, less than 1% serum addition could not support cell adhesion and proliferation, and over 10% serum addition significantly diminished the expansion of SP cells. In 1% FBS containing StemPro-34SFM, small spindle-like cells were expanded, and formations of small colonies were observed. Therefore, we determined the ideal culture condition for the synovial SP cells to be 1% FBS containing StemPro-34SFM.
Characteristics of SP cells
After preculture in 1% FBS containing StemPro-34SFM, we examined the characterization of cultured SP cells for the stem cell markers. The SP cells showed significantly higher expression, than NSP cells, of somatic stem cell marker genes CD34, Flk-1, and Abcg-2 (Figure 3).
Culturing and analysis of SP cells
To stably supply transplantable cells, ex vivo amplification of the cells was required. Because we showed that SP cells in the synovial tissues could be amplified using precultured medium, i.e. SFM and 1% serum, sorted SP cells were cultured under the same condition; however, the SP cells after sorting did not adhere and proliferate. It is possible that, in primary culture, co-existence of variable types of cells including blood cells secret some cytokines or cell adhesion molecules in an autocrine or paracrine fashion, and support the adhesion and proliferation of SP cells. Next, we examined the effect of bFGF, SCF and fibronectin on the adhesion and growth of the SP cells. Sorted SP cells exhibited small spindle-like features and formed colonies when cultured in the condition with these supplementations, on the other hand, NSP cells did not form colonies, and the proliferation speed was low. In the culture condition, the SP cells exhibited logarithmic proliferation even after 10 passages and Ho-efflux properties were also maintained. Furthermore, the SP cells expressed marker genes CD34, Flk-1, c-Kit and Abcg-2 (Figure 4).
Determination of multiple differentiation potentials
To confirm the multilineage differentiation potential, SP cells, which were expanded ex vivo and passaged more than 7 times, were induced to differentiate into chondrocyte, osteocyte and myocyte. In chondrogenic culture, the cell pellets became spherical, and the pellets from SP cells tended to have greater amounts of cartilage matrix than did pellets from NSP cells as shown by staining with toluidine blue and alcian blue. RT-PCR analysis demonstrated further characterization of chondrogenesis, and chondrocyte specific genes COL2A1, CD-RAP and Aggrecan were determined.
SP cells also had differentiation potentials to become osteocyte and myocyte. About the osteogenic potentials, no remarkable difference was observed between the origins, i.e. SP cells and NSP cells. On the other hand, myogenic property was only observed in SP cells. Desmin expressing myocytes were detected in the derivatives of SP cells, and these cells expressed other myogenic marker genes Myf-5 and Myo-D (Figure 5).
In the present study, we determined stem cell specific marker gene expression of SP cells in bovine synovial membrane, and constructed a culture system for efficient collection and ex vivo expansion of the stem cells. Recently, Yamane et al. reported that the SP fraction was only 0.6 % in the synovium tissues at the medial and lateral femoral condyles of 3-month-old calves . On the other hand, we observed SP fractions in about 2 % of the total cells. Furthermore, the flow cytometric profile of the two reports was totally different. This discrepancy might be due to differences of tissue origins, it is possible that the numbers of SP cells were different in the area of synovium tissues. Another factor might be based on the difference in the cell sorting condition. For instance, they used 10 μg/ml of Hoechst 33342 dye and we used it at 1.8 – 2.0 μg/ml. The experiment for determination of SP cells was dependent on the staining protocol which is subject to variations in timing, temperature, cell concentration, and Ho-dye concentration. We first determined the gene expression profile of bovine synovium SP cells using some stem cell markers such as CD34, c-Kit, Flk-1, Abcg-2 and Mdr-1. CD34 is a transmembrane sialoglycoprotein expressed by early hematopoietic stem cells . Flk-1 is a receptor for vascular endothelial growth factor, and a marker for progenitor cells of hematopietic and endothelial lineage . C-Kit, also known as CD117, is a receptor for stem cell factor and is expressed in various stem cells and hematopoietic progenitor cells [27, 28]. Abcg-2 is the molecular determinant for the SP phenotype and has been postulated as a universal stem cell marker . These gene expressions were observed in some somatic stem cells, and it is thought these are important for stem cell characteristics mainly to maintain their stem-ness. The synovium SP cells also expressed these markers and there was also additional evidence for stem cells.
Although the stem cells collected as SP cells possessed valuable characteristics for stem cell based therapy, the important factor in tissue engineering is to harvest the greatest number of cells with the highest potential while minimizing the amount of mesenchymal tissue needed, for less-invasive treatments. In this context, clearly the most important contribution of our study is the finding that the SP cells could be expanded ex vivo under specific conditions. We found that a combination of 1% FBS and StemPro-34SFM is ideal for enhancing SP cell proliferation. Under this condition, the rates of SP fractions were up to over 8% of total cells. Interestingly, increased supplementation of serum to over 10% inhibited the proliferation of the SP cells [see Additional file 4]. It is possible that the high serum concentration induced SP cells to differentiate into somatic cells and promoted expansion of differentiated cells, which caused the relative rate of SP fractions to decrease.
On the other hand, under the conditions of less than 1%, adherent cells were decreased and getting enough cells for cell sorting was difficult. When SP cells were cultured in StemPro-34SFM with 1% FBS, the expressions of stem cell markers were maintained. When ordinal culture medium DMEM was used as basement medium, effects for expansion and decreasing the rates of SP fractions dependent on serum concentrations were not observed. StemPro34-SFM is a medium specifically developed for CD34 expressing hematopoietic stem cell culture and the effects for other types of stem cell such as spermatogonial stem cells were reported [30–32]. Although the mechanism or molecules by which the expansion of SP cells were stimulated in the medium is not known, the factors necessary for the maintenance of these stem cells are the defined components of StemPro34-SFM, and may be shared with hematopoietic stem cells.
To achieve further enhancement of the cell number, we then examined the conditions for ex vivo expansion of sorted SP cells. For maintaining the SP cell proliferation while keeping their specific characters as stem cells, we found that the supplementation with three factors (bFGF, SCF and Fn) was effective. The FGF families are important factors for proliferation of variable stem cells such as mesenchymal stem cell (MSC) [33, 34], neural stem cell , and embryonic stem cell [36, 37]. SCF plays an important role via a c-Kit receptor in the recruitment of adult hematopoietic stem cells , or formation of germ stem cells in vivo . Also in vitro, SCF is an essential factor for the maintenance of hematopoietic stem cell [38–40]. Fn is a kind of extra-cellular matrix glycoprotein, which functions in promoting cell adhesion. In hematopoietic tissues, stem cells adhere to the Fn and endothelial vascular cell adhesion molecule (V-CAM) by integrin and cell surface glycosaminoglycans . And the molecule functions as the crucial factor for maintenance of ex vivo culture [41, 42]. The above culture condition enables the logarithmic expansion while maintaining some important original characteristics. After continued passaging and culturing, the expression of CD34, Flk-1 and Abcg-2 mRNA was still maintained at a high-rate compared with NSP cells. Importantly, this Abcg-2 mRNA expression reflected as the phenotype that the cultured SP cells also represented the Ho-efflux properties and Ver-sensitivity. However, the FACS profiles were little different from the original profiles of SP fractions. It was supposed that the valance of the two kinds of Ho-efflux proteins Abcg-2 and Mdr-1 were altered from original cells. This profile was observed only in SP cell derivatives, and it was lost with differentiation (data not shown).
Recently, it was reported that cells expressing CD34 and CD117 (c-Kit) exist at <2%, and cells expressing Flk-1 exist at <4%, in synovial tissues . Although the expression of these molecules was an important phenotype of stem cells, the expression of Flk-1 was diminished by ex vivo culture when cultured in normal medium . The SP cells cultured in our system maintained other markers CD34, Flk-1 and c-Kit expressions. From these, our system might be suitable for maintaining undifferentiated stem cells in synovium tissues.
Furthermore, we also demonstrated multiple differentiation potentials for synovial SP cells into chondrocyte, osteocyte and myocyte. In our study, NSP cells used as control also possessed differentiation properties to differentiate into chondrocyte and osteocyte. It was hypothesized that NSP fractions might include some kind of progenitor cells that could differentiate into chondrocyte or osteocyte. On the other hand, myogenic properties were only observed in SP cells. As stimulating chemicals for myogenic differentiation from somatic stem cells such as MSC in vitro, 5' azacytidine that is an analog of cytidine, were used [43, 44]. The chemical functions by incorporation into DNA, and results in hypomethylation of the DNA. On the other hand, transplantation to muscular tissues also induces myocyte differentiation from MSCs derived from synovium tissues . However, in our study, the SP cells could differentiate to myocyte without the chemical or transplantation, about 1% of derivatives expressed Desmin, a muscle-specific intermediate filament protein. These results mean that the myogenesis from SP cells might occur as the "forward" differentiation, and suggested that the SP cells maintained high differentiation potentials.
We first demonstrated the capacity of SP cells in the synovial tissue to proliferate ex vivo and differentiate into chondrocytes, osteocytes and myocytes. Although further studies are required to demonstrate that SP cells are transplantable stem cells after ex vivo expansion, the present findings might lead to the development of an effective method for preparing materials for cell-based therapy.
ATP-binding cassette subfamily G member-2
Multi Drug Resistance-1
Fetal liver kinase 1
fatal bovine serum
Dulbecco's modified Eagle's medium
fluorescence activated cell sorter
Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994, 331: 889-895. 10.1056/NEJM199410063311401.
Biant LC, Bentley G: Stem cells and debrided waste: two alternative sources of cells for transplantation of cartilage. J Bone Joint Surg Br. 2007, 89: 1110-1114. 10.1302/0301-620X.89B8.18911.
Sakaguchi Y, Sekiya I, Yagishita K, Muneta T: Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005, 52: 2521-2529. 10.1002/art.21212.
Mochizuki T, Muneta T, Sakaguchi Y, Nimura A, Yokoyama A, Koga H, Sekiya I: Higher chondrogenic potential of fibrous synovium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells: distinguishing properties of mesenchymal stem cells in humans. Arthritis Rheum. 2006, 54: 843-853. 10.1002/art.21651.
Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996, 183: 1797-1806. 10.1084/jem.183.4.1797.
Cai J, Cheng A, Luo Y, Lu C, Mattson MP, Rao MS, Furukawa K: Membrane properties of rat embryonic multipotent neural stem cells. J Neurochem. 2004, 88: 212-26.
Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001, 107: 1395-1402. 10.1172/JCI12150.
Jackson KA, Mi T, Goodell MA: Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA. 1999, 96: 14482-14486. 10.1073/pnas.96.25.14482.
Uchida N, Leung FY, Eaves CJ: Liver and marrow of adult mdr-1a/1b(-/-) mice show normal generation, function, and multi-tissue trafficking of primitive hematopoietic cells. Exp Hematol. 2002, 30: 862-869. 10.1016/S0301-472X(02)00879-2.
Shimano K, Satake M, Okaya A, Kitanaka J, Kitanaka N, Takemura M, Sakagami M, Terada N, Tsujimura T: Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1. Am J Pathol. 2003, 163: 3-9.
Majka SM, Beutz MA, Hagen M, Izzo AA, Voelkel N, Helm KM: Identification of novel resident pulmonary stem cells: form and function of the lung side population. Stem Cells. 2005, 23: 1073-1081. 10.1634/stemcells.2005-0039.
Yano S, Ito Y, Fujimoto M, Hamazaki TS, Tamaki K, Okochi H: Characterization and localization of side population cells in mouse skin. Stem Cells. 2005, 23: 834-41. 10.1634/stemcells.2004-0226.
Ono M, Maruyama T, Masuda H, Kajitani T, Nagashima T, Arase T, Ito M, Ohta K, Uchida H, Asada H, Yoshimura Y, Okano H, Matsuzaki Y: Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells. Proc Natl Acad Sci USA. 2007, 104: 18700-5. 10.1073/pnas.0704472104.
Lassalle B, Bastos H, Louis JP, Riou L, Testart J, Dutrillaux B, Fouchet P, Allemand I: 'Side Population' cells in adult mouse testis express Bcrp1 gene and are enriched in spermatogonia and germinal stem cells. Development. 2004, 131: 479-87. 10.1242/dev.00918.
Du Y, Funderburgh ML, Mann MM, SundarRaj N, Funderburgh JL: Multipotent stem cells in human corneal stroma. Stem Cells. 2005, 23: 1266-1275. 10.1634/stemcells.2004-0256.
Umemoto T, Yamato M, Nishida K, Yang J, Tano Y, Okano T: Limbal epithelial side-population cells have stem cell-like properties, including quiescent state. Stem Cells. 2006, 24: 86-94. 10.1634/stemcells.2005-0064.
Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC: Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999, 401: 390-394.
Yamane S, Reddi AH: Induction of chondrogenesis and superficial zone protein accumulation in synovial side population cells by BMP-7 and TGF-beta1. J Orthop Res.
Dussault AA, Pouliot M: Rapid and simple comparison of messenger RNA levels using real-time PCR. Biol Proced Online. 2006, 8: 1-10. 10.1251/bpo114.
Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001, 7: 1028-1034. 10.1038/nm0901-1028.
Bunting KD: ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells. 2002, 20: 11-20. 10.1634/stemcells.20-3-274.
Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG, Cowan K: The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res. 2002, 8: 22-28.
Scharenberg CW, Harkey MA, Torok-Storb B: The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood. 2002, 99: 507-512. 10.1182/blood.V99.2.507.
Bunting KD, Zhou S, Lu T, Sorrentino BP: Enforced P glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood. 2000, 96: 902-909.
Healy L, May G, Gale K, Grosveld F, Greaves M, Enver T: The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc Natl Acad Sci USA. 1995, 92: 12240-12244. 10.1073/pnas.92.26.12240.
Kabrun N, Bühring HJ, Choi K, Ullrich A, Risau W, Keller G: Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development. 1997, 124: 2039-2048.
Keller JR, Ortiz M, Ruscetti FW: Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division. Blood. 1995, 86: 1757-1764.
Mauduit C, Hamamah S, Benahmed M: Stem cell factor/c-kit system in spermatogenesis. Hum Reprod Update. 1999, 5: 535-545. 10.1093/humupd/5.5.535.
Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001, 7: 1028-1034. 10.1038/nm0901-1028.
Dolznig H, Boulmé F, Stangl K, Deiner EM, Mikulits W, Beug H, Müllner EW: Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays. FASEB J. 2001, 15: 1442-1444.
Kanatsu-Shinohara M, Lee J, Inoue K, Ogonuki N, Miki H, Toyokuni S, Ikawa M, Nakamura T, Ogura A, Shinohara T: Pluripotency of a Single Spermatogonial Stem Cell in Mice. Biol Reprod. 2008,
Seandel M, James D, Shmelkov SV, Falciatori I, Kim J, Chavala S, Scherr DS, Zhang F, Torres R, Gale NW, Yancopoulos GD, Murphy A, Valenzuela DM, Hobbs RM, Pandolfi PP, Rafii S: Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. Nature. 2007, 449: 346-350. 10.1038/nature06129.
Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R: Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res. 2003, 287: 98-105. 10.1016/S0014-4827(03)00138-1.
Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y: Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun. 2001, 288: 413-419. 10.1006/bbrc.2001.5777.
Kosaka N, Kodama M, Sasaki H, Yamamoto Y, Takeshita F, Takahama Y, Sakamoto H, Kato T, Terada M, Ochiya T: FGF-4 regulates neural progenitor cell proliferation and neuronal differentiation. FASEB J. 2006, 20: 1484-1485. 10.1096/fj.05-5293fje.
Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA: Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods. 2005, 2: 185-190. 10.1038/nmeth744.
Levenstein ME, Ludwig TE, Xu RH, Llanas RA, Heuvel-Kramer VanDen K, Manning D, Thomson JA: Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells. 2006, 24: 568-574. 10.1634/stemcells.2005-0247.
Ema H, Takano H, Sudo K, Nakauchi H: In vitro self-renewal division of hematopoietic stem cells. J Exp Med. 2000, 192: 1281-1288. 10.1084/jem.192.9.1281.
Miller CL, Rebel VI, Helgason CD, Lansdorp PM, Eaves CJ: Impaired steel factor responsiveness differentially affects the detection andlong-term maintenance of fetal liver hematopoietic stem cells in vivo. Blood. 1997, 89: 1214-1223.
Domen J, Weissman IL: Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J Exp Med. 2000, 192: 1707-1718. 10.1084/jem.192.12.1707.
Moritz T, Dutt P, Xiao X, Carstanjen D, Vik T, Hanenberg H, Williams DA: Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood. 1996, 88: 855-862.
Dao MA, Hashino K, Kato I, Nolta JA: Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood. 1998, 92: 4612-4621.
De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP: Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001, 44: 1928-1942. 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P.
Belema Bedada F, Technau A, Ebelt H, Schulze M, Braun T: Activation of myogenic differentiation pathways in adult bone marrow-derived stem cells. Mol Cell Biol. 2005, 25: 9509-9519. 10.1128/MCB.25.21.9509-9519.2005.
De Bari C, Dell'Accio F, abeele Vanden F, Vermeesch JR, Raymackers JM, Luyten FP: Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol. 2003, 160: 909-918. 10.1083/jcb.200212064.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/9/86/prepub
We gratefully acknowledge Mr. Bob Perkins and Ms. Naomi Backes Kamimura, Department of Biology Oriented Science and Technology, Kinki University, for English editing, and we thank Mr. Toshiyuki Takehara, Department of Biology Oriented Science and Technology, Kinki University, for editing assistance.
The authors declare that they have no competing interests.
TT carried out the cell culture, molecular genetic studies, immunocytochemical assays and drafted the manuscript. KF carried out the design of the study and prepared the manuscript. SK participated in the cell sorting. YH participated in the design of the study and performed the statistical analysis. YM carried out the tissue preparing and cell culture. SA participated in the preparation of the materials. CH conceived of the study, and participated in its design and coordination and helped to draft the manuscript.
Kanji Fukuda, Shinji Kurashimo, Yoshihiko Hosoi, Yoshihisa Miki, Shigeki Asada and Chiaki Hamanishi contributed equally to this work.
Electronic supplementary material
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.